Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19721 | 428 | 28.1 | 43% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2301 | 4109 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//APHERESIS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ANIM PHYSIOL SECT | Address | 11 | 67% | 2% | 10 |
| 2 | PROSORBA | Author keyword | 8 | 100% | 1% | 5 |
| 3 | PROTEIN A IMMOBILIZATION | Author keyword | 2 | 67% | 0% | 2 |
| 4 | TH1 TH2 PATHWAY | Author keyword | 2 | 67% | 0% | 2 |
| 5 | ANTIIDIOTYPIC IGG ANTIBODY | Author keyword | 1 | 100% | 0% | 2 |
| 6 | CHANIN CANC | Address | 1 | 50% | 0% | 2 |
| 7 | IDIOTYPIC IGG ANTIBODY | Author keyword | 1 | 100% | 0% | 2 |
| 8 | LOCAL STAPHYLOCOCCAL PROTEIN A | Author keyword | 1 | 100% | 0% | 2 |
| 9 | PROTEIN A LEAKAGE | Author keyword | 1 | 100% | 0% | 2 |
| 10 | IMMUNOTECHNOL SECT | Address | 1 | 10% | 3% | 12 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PROSORBA | 8 | 100% | 1% | 5 | Search PROSORBA | Search PROSORBA |
| 2 | PROTEIN A IMMOBILIZATION | 2 | 67% | 0% | 2 | Search PROTEIN+A+IMMOBILIZATION | Search PROTEIN+A+IMMOBILIZATION |
| 3 | TH1 TH2 PATHWAY | 2 | 67% | 0% | 2 | Search TH1+TH2+PATHWAY | Search TH1+TH2+PATHWAY |
| 4 | ANTIIDIOTYPIC IGG ANTIBODY | 1 | 100% | 0% | 2 | Search ANTIIDIOTYPIC+IGG+ANTIBODY | Search ANTIIDIOTYPIC+IGG+ANTIBODY |
| 5 | IDIOTYPIC IGG ANTIBODY | 1 | 100% | 0% | 2 | Search IDIOTYPIC+IGG+ANTIBODY | Search IDIOTYPIC+IGG+ANTIBODY |
| 6 | LOCAL STAPHYLOCOCCAL PROTEIN A | 1 | 100% | 0% | 2 | Search LOCAL+STAPHYLOCOCCAL+PROTEIN+A | Search LOCAL+STAPHYLOCOCCAL+PROTEIN+A |
| 7 | PROTEIN A LEAKAGE | 1 | 100% | 0% | 2 | Search PROTEIN+A+LEAKAGE | Search PROTEIN+A+LEAKAGE |
| 8 | BASE LABILE LINKER | 1 | 50% | 0% | 1 | Search BASE+LABILE+LINKER | Search BASE+LABILE+LINKER |
| 9 | IMMUNOADSORPTION TREATMENT | 1 | 50% | 0% | 1 | Search IMMUNOADSORPTION+TREATMENT | Search IMMUNOADSORPTION+TREATMENT |
| 10 | IMMUNOSORBA | 1 | 50% | 0% | 1 | Search IMMUNOSORBA | Search IMMUNOSORBA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CYCLOPHOSPHAMIDE TOXICITY | 4 | 75% | 1% | 3 |
| 2 | PLASMA ADSORPTION | 3 | 100% | 1% | 3 |
| 3 | A IMMUNOADSORPTION | 3 | 35% | 2% | 7 |
| 4 | PROSORBA COLUMN | 2 | 50% | 1% | 3 |
| 5 | STAPHYLOCOCCAL PROTEIN | 2 | 29% | 1% | 5 |
| 6 | INVIVO PROTECTION | 1 | 31% | 1% | 4 |
| 7 | ANTI AIDS DRUG | 1 | 100% | 0% | 2 |
| 8 | ANTI GLOBULINS | 1 | 50% | 0% | 2 |
| 9 | DIFFUSIBLE SUBSTANCES | 1 | 50% | 0% | 2 |
| 10 | EXVIVO REMOVAL | 1 | 100% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Russian Pioneers of Therapeutic Hemapheresis and Extracorporeal Hemocorrection: 100-Year Anniversary of the World's First Successful Plasmapheresis | 2014 | 1 | 2 | 100% |
| Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis | 2002 | 9 | 10 | 70% |
| Background and indications for protein A-based extracorporeal immunoadsorption | 2001 | 19 | 73 | 41% |
| Extracorporeal removal of circulating immune complexes: Front non-selective to patient-specific | 2000 | 4 | 11 | 45% |
| Protein A immunoadsorption - Clinical potential | 1996 | 2 | 65 | 58% |
| PROTEIN-A AND STAPHYLOCOCCAL PRODUCTS IN NEOPLASTIC DISEASE | 1985 | 8 | 40 | 63% |
| THE PATHO-PHYSIOLOGY OF CIRCULATING IMMUNE-COMPLEXES - THEIR ROLE IN HOST TUMOR INTERACTIONS AND REMOVAL BY IMMUNOADSORPTION THERAPY | 1985 | 13 | 20 | 40% |
| A new concept in cancer chemoprevention | 1996 | 0 | 15 | 40% |
| PROTEIN-A IMMUNOADSORPTION IMMUNOACTIVATION - A CRITICAL-REVIEW | 1985 | 2 | 26 | 88% |
| BLOCKING (SUPPRESSOR) FACTORS, IMMUNE-COMPLEXES, AND EXTRACORPOREAL IMMUNOADSORPTION IN TUMOR-IMMUNITY | 1985 | 9 | 45 | 44% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANIM PHYSIOL SECT | 11 | 67% | 2.3% | 10 |
| 2 | CHANIN CANC | 1 | 50% | 0.5% | 2 |
| 3 | IMMUNOTECHNOL SECT | 1 | 10% | 2.8% | 12 |
| 4 | AKUTKLIN RHEUMATOL ALLGEMEINKRANKENHAUS | 1 | 50% | 0.2% | 1 |
| 5 | EXCELLENCE POLYMER BIOMAT | 1 | 29% | 0.5% | 2 |
| 6 | HLTH SCI OFF | 0 | 33% | 0.2% | 1 |
| 7 | SPECIAL MAT S | 0 | 33% | 0.2% | 1 |
| 8 | EMI 9940 | 0 | 25% | 0.2% | 1 |
| 9 | SURGKAMIGYO KU | 0 | 25% | 0.2% | 1 |
| 10 | QUAL ASSURANCE DIRECT | 0 | 20% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000292384 | THEODORE GILDRED CANC//PROTEIN L//STAPHYLOCOCCAL PROTEIN A |
| 2 | 0.0000232170 | MULTIVALENT IMMUNOTOXINS//KINETIC PARAMETERS OF BINDING//CHRONIC LYMPHOLEUKEMIA |
| 3 | 0.0000114394 | ANTIBODY TO HEPATITIS C VIRUS//ANGIONEUROL//ANTIGEN ANTIBODY DOCKING |
| 4 | 0.0000112794 | THERAPEUTIC APHERESIS//THERAPEUTIC PLASMA EXCHANGE//PLASMA EXCHANGE |
| 5 | 0.0000090649 | CALVATIC ACID AND DERIVATIVES//2 THIOUREIDOBENZOXAZOLE//CATTEDRA MICROBIOL CLIN 1 |
| 6 | 0.0000085806 | INTRAVENOUS LASER RADIATION OF BLOOD//INTERNAL DIS 3//ACUTE RADIATION DISEASE |
| 7 | 0.0000080749 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//LIPOPROTEIN APHERESIS |
| 8 | 0.0000073163 | BILIRUBIN REMOVAL//BILIRUBIN ADSORPTION//SPECIFIC SORBENTS |
| 9 | 0.0000065681 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY//J11D//MED ICRF HUMAN TUMOUR IMMUNOL GRP |
| 10 | 0.0000060616 | P15E//CKS 17//ADV MED TREATMENTS |